-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SNkztAECv5wWScnypSR7au0WMK2AGSsk0kDoJWDu2G0lmXYgzhMjryidKPZu4SKl 4itL9asX9/tdfCgdD9IKhA== 0001021408-98-000409.txt : 19980622 0001021408-98-000409.hdr.sgml : 19980622 ACCESSION NUMBER: 0001021408-98-000409 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 19980619 SROS: AMEX GROUP MEMBERS: DOUGLAS D. THOMAS GROUP MEMBERS: THOMAS WILMER J JR GROUP MEMBERS: WILLIAM D. PORTEOUS SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MOORE MEDICAL CORP CENTRAL INDEX KEY: 0000074691 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 221897821 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-07421 FILM NUMBER: 98650853 BUSINESS ADDRESS: STREET 1: PO BOX 1500 STREET 2: 389 JOHN DOWNEY DR CITY: NEW BRITAIN STATE: CT ZIP: 06050 BUSINESS PHONE: 2038263600 MAIL ADDRESS: STREET 1: 389 JOHN DOWNEY DRIVE STREET 2: 389 JOHN DOWNEY DRIVE CITY: NEW BRITAIN STATE: CT ZIP: 06050 FORMER COMPANY: FORMER CONFORMED NAME: OPTEL CORP DATE OF NAME CHANGE: 19850611 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: THOMAS WILMER J JR CENTRAL INDEX KEY: 0001004065 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 272 UNDER MOUNTAIN RD CITY: SALISBURY STATE: CT ZIP: 06068 MAIL ADDRESS: STREET 1: 272 UNDER MOUNTAIN RD CITY: SALISBURY STATE: CT ZIP: 06068 SC 13D/A 1 SCHEDULE 13D/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ____________ SCHEDULE 13D (Rule 13d-101)/1/ INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 1(a)) Moore Medical Corp. ---------------------------------------------------------------------- (Name of Issuer) Common Stock, $.01 par value ---------------------------------------------------------------------- (Title of Class of Securities) ---------------------------------------------------------------------- (CUSIP Number) Joseph Greenberger 1370 Avenue of the Americas New York, NY 10019 ---------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) May 6, 1998 ---------------------------------------------------------------------- (Date of Event Which Requires Filing of This Statement) ____________________ /1/ The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or (4), check the following box / /. (a) Constitutes Amendment No. 1 to the Schedule 13D of Wilmer J. Thomas, Jr. (amending his Schedule 13D filed with respect to Optel Corporation, the Issuer's former corporate name), and the initial Schedule 13D of Douglas D. Thomas and William D. Porteous.
CUSIP NO. 615799 10 3 13D PAGE 1 OF 9 PAGES ========================================================================================================================= 1 NAMES OF REPORTING PERSONS Wilmer J. Thomas, Jr. Douglas D. Thomas William D. Porteous S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS Wilmer J. Thomas, Jr. S.S. No. ###-##-#### Douglas D. Thomas S.S. No. ###-##-#### William D. Porteous S.S. No. ###-##-#### - ------------------------------------------------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP Wilmer J. Thomas, Jr. (a)/x/ (b)/ / Douglas D. Thomas (a)/x/ (b)/ / William D. Porteous (a)/x/ (b)/ / - ------------------------------------------------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO - ------------------------------------------------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) - ------------------------------------------------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Wilmer J. Thomas, Jr. - USA Douglas D. Thomas - USA William D. Porteous - USA - ------------------------------------------------------------------------------------------------------------------------- 7 SOLE VOTING POWER Wilmer J. Thomas, Jr. 0 Douglas D. Thomas 0 William D. Porteous 0 - ------------------------------------------------------------------------------------------------------------------------- NUMBER OF 8 SHARED VOTING POWER SHARES Wilmer J. Thomas, Jr. 213,243 BENEFICIALLY Douglas D. Thomas 213,243 OWNED BY William D. Porteous 213,243 EACH ----------------------------------------------------------------------------------------------- REPORTING 9 SOLE DISPOSITIVE POWER PERSON WITH Wilmer J. Thomas, Jr. 0 Douglas D. Thomas 0 William D. Porteous 0 - -------------------------------------------------------------------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER Wilmer J. Thomas, Jr. 213,243 Douglas D. Thomas 213,243 William D. Porteous 213,243 - -------------------------------------------------------------------------------------------------------------------------
CUSIP NO. 615799 10 3 13D PAGE 2 OF 9 PAGES - ------------------------------------------------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON Wilmer J. Thomas, Jr. 213,243 Douglas D. Thomas 213,243 William D. Porteous 213,243 - ------------------------------------------------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES / / - ------------------------------------------------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) Wilmer J. Thomas, Jr. 7.27% Douglas D. Thomas 7.27% William D. Porteous 7.27% - ------------------------------------------------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* Wilmer J. Thomas, Jr. - IN Douglas D. Thomas - IN William D. Porteous - IN =========================================================================================================================
*SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP NO. 615799 10 3 13D PAGE 3 OF 9 PAGES STATEMENT FOR SCHEDULE 13D -------------------------- Item 1. Security and Issuer. - ------- -------------------- The class of equity securities to which this Statement relates is the common stock, $.01 par value ("Shares"), of Moore Medical Corp., a Delaware corporation (the "Issuer"), whose principal executive office is located at 389 John Downey Drive, New Britain, CT 06050-2740. Item 2. Identity and Background. - ------- ------------------------ (a) The persons filing this statement are Wilmer J. Thomas, Jr., Douglas D. Thomas and William D. Porteous, as co-trustees of the Thomas Charitable Foundation, a trust established pursuant to the laws of Florida (the "Foundation"). Each such person is referred to as a "Reporting Person" and collectively as the "Reporting Persons". (b) The residence address of Wilmer J. Thomas, Jr., is 272 Undermountain Road, Salisbury, CT 06068-1510. The residence address of Douglas D. Thomas is 272 Undermountain Road, Salisbury, CT 06068-1510. The residence address of William D. Porteous is 46 Western Avenue, Cambridge, MA 12139. (c) The principal occupation of Wilmer J. Thomas, Jr., is private investor. The principal occupation of Douglas D. Thomas is an investor in an agricultural business. The principal employment of William D. Porteous is product manager of Supplyworks, Inc. (internet commerce), 57 Bedford St., Lexington, MA 02173. (d) No Reporting Person has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) No Reporting Person has, during the last five years, been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, CUSIP NO. 615799 10 3 13D PAGE 4 OF 9 PAGES federal or state securities laws or finding any violation with respect to such laws. Item 3. Source and Amount of Funds or Other Consideration. - ------- -------------------------------------------------- The Foundation acquired 241,243 Shares on May 6, 1998, as a charitable gift from Wilmer J. Thomas, Jr. Other than by reason of his or her shared voting and dispositive power as a co-trustee under the Foundation's trust instrument, no Reporting Person has any beneficial interest in any Shares of the Issuer. Item 4. Purpose of Transaction. - ------- ----------------------- The Reporting Persons have no present plan or proposal with respect to the Issuer. Pursuant to regulatory requirements to which the Foundation is subject, the Reporting Persons expect the Foundation to sell, annually, not less than 5% of the remaining Shares held by the Foundation. Depending on various factors, including the distribution of such amounts as may be decided upon to such persons or entities as may be selected as Foundation distributees, the Issuer's business affairs and financial position, the price levels of its Common Stock, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may in the future take such other actions with respect to the Foundation's investment in the Issuer as they deem appropriate in light of the circumstances existing from time to time. Item 5. Interest in Securities of the Issuer. - ------- ------------------------------------- (a) The aggregate percentage of shares of Common Stock reported owned by each Reporting Person is based upon 2,932,061 shares of such class outstanding. As of the date of this Schedule, the Foundation owned, of record, and each Reporting Person owned, beneficially, 213,243 Shares, constituting approximately 7.27% of the shares outstanding of that class. (b) The Reporting Persons share the voting and dispositive power, by majority vote, of any securities held by the Foundation. (c) No Reporting Person has engaged in any transaction in the shares of Common Stock during the past sixty days except as set forth on Exhibit 1 attached hereto. (d) No person other than the Foundation is known to have the right to receive, and no person other than the Reporting Persons is known to have the power to direct the receipt of dividends from, or to the proceeds from, the sale of such shares of the Common Stock. CUSIP NO. 615799 10 3 13D PAGE 5 OF 9 PAGES (e) Not applicable. Item 6. Contracts, Arrangements, Understandings or Relationships with Respect - ------- --------------------------------------------------------------------- to Securities of the Issuer. - ---------------------------- Except in their capacity as co-trustees under the Foundation's trust instrument, no Reporting Person has any contracts, arrangements, understandings or relationships with respect to the securities of the Issuer. Item 7. Material to be Filed as Exhibits. - ------- --------------------------------- 1. Schedule of trading by Reporting Persons within the past 60 days (filed herewith). 2. Powers of Attorney from each Reporting Person to Mr. William J. Thomas, Jr. (filed herewith). 3. Joint Filing Agreement, pursuant to Rule 13d-1(f), among Wilmer J. Thomas, Jr., and each of the Reporting Persons (filed herewith). SIGNATURES ---------- After reasonable inquiry and to the best of their knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: June 16, 1998 /s/ Wilmer J. Thomas, Jr. _________________________________________ WILMER J. THOMAS, JR. /s/ Douglas D. Thomas _________________________________________ DOUGLAS D. THOMAS /s/ William D. Porteous _________________________________________ WILLIAM D. PORTEOUS CUSIP NO. 615799 10 3 13D PAGE 6 OF 9 PAGES Exhibit Index ------------- Exhibit 1 - Trading within past 60 days Page 7 Exhibit 2 - Powers Of Attorney for each Page 8 Reporting Person Exhibit 3 - Joint Filing Agreement Page 9 among the Reporting Persons EX-99.1 2 TRADING WITHIN PAST 60 DAYS CUSIP NO. 615799 10 3 13D PAGE 7 OF 9 PAGES EXHIBIT 1 Below is certain information regarding the Foundation's and each Reporting Person's transaction history in the securities of the Issuer during the past 60 days:
No. of Name Date Transaction Shares - -------------------------------------------------------------------------------- William J. Thomas, Jr. 5/06/98 Gift transfer 241,248 Thomas Charitable Foundation 5/06/98 Gift receipt 241,248 Thomas Charitable Foundation 5/11/98 Sold 28,000
EX-99.2 3 POWER OF ATTORNEY CUPID NO. 615799 10 3 13D PAGES 8 OF 9 PAGES EXHIBIT 2 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that Douglas D. Thomas and William D. Porteous, whose signatures appear below, each constitutes and appoints Wilmer J. Thomas, Jr., as attorney-in-fact and agent for the undersigned solely for the purpose of executing and filing reports required under Section 13 of the Securities and Exchange Act of 1934, with exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, thereby ratifying and confirming all that said attorney-in fact may do or cause to be done by virtue hereof. Date: June 16, 1998 /s/ Douglas D. Thomas --------------------------------- DOUGLAS D. THOMAS /s/ William D. Porteous --------------------------------- WILLIAM D. PORTEOUS EX-99.3 4 JOINT FILING AGREEMENT CUSIP NO. 615799 10 3 13D PAGE 9 OF 9 PAGES Exhibit 3 JOINT FILING AGREEMENT In accordance with Rule 13d-1(f) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the shares of common stock of beneficial interest, par value $.01 per share, of Moore Medical Corp. and further agree that this Joint Filing Agreement (this "Agreement") be included as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement. This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed an original and all of which together shall constitute one and the same instrument. WILMER J. THOMAS, JR. By: /s/ Wilmer J. Thomas, Jr. ---------------------------------- Name: Wilmer J. Thomas, Jr. Title: Attorney-in-fact Dated: June 16, 1998 DOUGLAS D. THOMAS By: /s/ Wilmer J. Thomas, Jr. ---------------------------------- Name: Wilmer J. Thomas, Jr. Title: Attorney-in-fact Dated: June 16, 1998 WILLIAM D. PORTEOUS By: /s/ Wilmer J. Thomas, Jr. ---------------------------------- Name: Wilmer J. Thomas, Jr. Title: Attorney-in-fact Dated: June 16, 1998 -----END PRIVACY-ENHANCED MESSAGE-----